These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23329516)

  • 21. To P or Not to P: Backing Bayesian Statistics.
    Buchinsky FJ; Chadha NK
    Otolaryngol Head Neck Surg; 2017 Dec; 157(6):915-918. PubMed ID: 29192853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enter the reverend: introduction to and application of Bayes' theorem in clinical ophthalmology.
    Thomas R; Mengersen K; Parikh RS; Walland MJ; Muliyil J
    Clin Exp Ophthalmol; 2011 Dec; 39(9):865-70. PubMed ID: 21575118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A permutation two one-sided tests procedure to detect minimal fold changes of gene expression levels.
    Liu JP; Liao CT; Chiu ST; Dai JY
    J Biopharm Stat; 2008; 18(5):808-26. PubMed ID: 18781518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why P is not perfect.
    Chopra V; Hayward RA
    Am J Med; 2012 Jun; 125(6):e1-2. PubMed ID: 22483057
    [No Abstract]   [Full Text] [Related]  

  • 25. Should we use one-sided or two-sided P values in tests of significance?
    Ludbrook J
    Clin Exp Pharmacol Physiol; 2013 Jun; 40(6):357-61. PubMed ID: 23551169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Analysis of Nonsignificant Results in Audiology Using Bayes Factors.
    Brydges CR; Gaeta L
    J Speech Lang Hear Res; 2019 Dec; 62(12):4544-4553. PubMed ID: 31805244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Bayesian predictive two-stage design for phase II clinical trials.
    Sambucini V
    Stat Med; 2008 Apr; 27(8):1199-224. PubMed ID: 17763528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interpretation of research data: hypothesis testing.
    Stolar MH
    Am J Hosp Pharm; 1980 Nov; 37(11):1539-45. PubMed ID: 7211860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simple estimators of false discovery rates given as few as one or two p-values without strong parametric assumptions.
    Bickel DR
    Stat Appl Genet Mol Biol; 2013 Aug; 12(4):529-43. PubMed ID: 23798617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Bayesian interpretation of a P-value depends only weakly on statistical power in realistic situations.
    Hooper R
    J Clin Epidemiol; 2009 Dec; 62(12):1242-7. PubMed ID: 19398295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bayes' theorem and diagnostic tests in neuropsychology: interval estimates for post-test probabilities.
    Crawford JR; Garthwaite PH; Betkowska K
    Clin Neuropsychol; 2009 May; 23(4):624-44. PubMed ID: 19235634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bayes factor and posterior probability: Complementary statistical evidence to p-value.
    Lin R; Yin G
    Contemp Clin Trials; 2015 Sep; 44():33-35. PubMed ID: 26212520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Branch-length prior influences Bayesian posterior probability of phylogeny.
    Yang Z; Rannala B
    Syst Biol; 2005 Jun; 54(3):455-70. PubMed ID: 16012111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Power and sample size when multiple endpoints are considered.
    Senn S; Bretz F
    Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of branch length uncertainty on Bayesian posterior probabilities for phylogenetic hypotheses.
    Kolaczkowski B; Thornton JW
    Mol Biol Evol; 2007 Sep; 24(9):2108-18. PubMed ID: 17636043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient two-stage genome-wide association designs based on false positive report probabilities.
    Kraft P
    Pac Symp Biocomput; 2006; ():523-34. PubMed ID: 17094266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing methods of analyzing fMRI statistical parametric maps.
    Marchini J; Presanis A
    Neuroimage; 2004 Jul; 22(3):1203-13. PubMed ID: 15219592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a misspecification of response rates on type I and type II errors, in a phase II Simon design.
    Baey C; Le Deley MC
    Eur J Cancer; 2011 Jul; 47(11):1647-52. PubMed ID: 21493059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of information and optimal clinical trial design.
    Willan AR; Pinto EM
    Stat Med; 2005 Jun; 24(12):1791-806. PubMed ID: 15806619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.